Oppenheimer Q2 Review on Cadence Pharma (CADX): Supply Shortage Not Expected From Recall
Go back to Oppenheimer Q2 Review on Cadence Pharma (CADX): Supply Shortage Not Expected From RecallCadence Pharmaceuticals, Inc. (NASDAQ: CADX) | Delayed: 13.98 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $13.98 | 52 Week High | $11.92 | |||
Open | $13.98 | 52 Week Low | $4.45 | |||
Day High | $13.98 | P/E | N/A | |||
Day Low | $13.98 | EPS | $-0.49 | |||
Volume | 282,940 |